{"id":58519,"date":"2023-12-04T16:05:11","date_gmt":"2023-12-04T15:05:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/"},"modified":"2023-12-04T16:05:11","modified_gmt":"2023-12-04T15:05:11","slug":"xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/","title":{"rendered":"XiFin CEO Urges Congress to Preserve Seniors\u2019 Access to Critical Diagnostic Testing by Supporting Saving Access to Laboratory Services Act"},"content":{"rendered":"
\n

SAN DIEGO–(BUSINESS WIRE)–#digitalpathology<\/a>–In a letter to the chairs and ranking members of the House Energy and Commerce Committee and Health Subcommittee, XiFin CEO L\u00e2le White urged policymakers to prioritize the Saving Access to Laboratory Services Act<\/i> (SALSA) to set Medicare payments for clinical laboratory services on a stable and sustainable pathway. White\u2019s appeal supports the position of the American Clinical Laboratory Association (ACLA), which led a Congressional appeal to drive a one-year delay in Protecting Access to Medicare Act<\/i> (PAMA) reductions and data reporting included the recent short-term spending package.<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cReinstating ill-conceived Medicare cuts at the end of this one-year freeze threatens to reduce patient access to testing, hamper research and innovation in laboratory services, and further undermine our nation\u2019s testing infrastructure,\u201d White said. \u201cAs a leading technology company supporting complex, multi-specialty testing laboratories, XiFin continues to express alarm at the harm inflicted on our nation\u2019s diagnostic infrastructure by the $3.8 billion in Medicare payment cuts for laboratory services that have occurred since the implementation of the Protecting Access to Medicare Act<\/i> (PAMA). That\u2019s why it\u2019s important to support SALSA in 2024.\u201d<\/p>\n

\nDespite repeated interventions by Congress to delay additional cuts \u2013 including the one-year delay included in the recent short-term spending package \u2013 policymakers have yet to set a sustainable policy to safeguard access to critical laboratory services. Without a long-term policy, laboratories again will face another round of payment cuts of up to 15 percent in January 2025 for approximately 800 tests under Medicare\u2019s Clinical Laboratory Fee Schedule (CLFS), due to the flawed implementation of PAMA.<\/p>\n

\nAt issue is the Centers for Medicare and Medicaid Services\u2019 (CMS) misinterpretation of PAMA\u2019s legislative intent to reform Medicare\u2019s CLFS. CMS has failed to base payment rates on truly representative market-based rates by independent laboratories, hospital laboratories, and physician office laboratories. The Saving Access to Laboratory Services Act<\/i>, H.R. 2377, would require statistical sampling to obtain representative, private payor data from independent laboratories, hospital laboratories, and physician office labs, in addition to other reforms intended to address unintended burdens caused by PAMA.<\/p>\n

\n\u201cWhile the one-year delay in Protecting Access to Medicare Act<\/i> (PAMA) reductions and data reporting protects patients relying on critical clinical laboratory services in the short-term, it is only a temporary reprieve,\u201d said White. \u201cXiFin urges Congress to adopt a more permanent fix, such as the Saving Access to Laboratory Services Act<\/i> (SALSA). Enactment of SALSA will be critical to preserving our nation\u2019s laboratory infrastructure and the high-quality clinical laboratory services patients and their providers rely upon to make vital medical decisions. On behalf of all the independent and hospital labs \u2013 which includes 12 of the top 15 publicly traded laboratories \u2013 XiFin serves, I respectfully urge the Health Subcommittee and the Energy and Commerce Committee to support SALSA to help preserve seniors\u2019 access to critical laboratory services.\u201d<\/p>\n

\nAbout XiFin<\/b><\/p>\n

\nXiFin is a healthcare information technology company that empowers healthcare organizations to navigate an increasingly complex and evolving healthcare landscape. Through innovative AI-enabled technologies and services, we deliver operational efficiency, interoperability, and simplicity. Our laboratory information system, revenue cycle management, clinical workflow enablement, and patient engagement solutions enable organizations to achieve stronger finances, streamline operations, and develop industry-leading business strategies. XiFin solutions deliver THE POWER TO DO GOOD\u2122 so that healthcare organizations can do more good for more patients. Visit www.XiFin.com<\/a>, follow XiFin on LinkedIn<\/a>, or subscribe to the XiFin blog<\/a> to learn more.<\/p>\n

Contacts<\/b> <\/p>\n

\nAudrey Chang<\/b>
(202)-489-8634<\/b>
a.chang@togorun.com<\/a><\/b><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–#digitalpathology–In a letter to the chairs and ranking members of the House Energy and Commerce Committee and Health Subcommittee, XiFin CEO L\u00e2le White urged policymakers to prioritize the Saving Access to Laboratory Services Act (SALSA) to set Medicare payments for clinical laboratory services on a stable and sustainable pathway. White\u2019s appeal supports the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58519","6":"format-standard","7":"category-industry"},"yoast_head":"\nXiFin CEO Urges Congress to Preserve Seniors\u2019 Access to Critical Diagnostic Testing by Supporting Saving Access to Laboratory Services Act - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XiFin CEO Urges Congress to Preserve Seniors\u2019 Access to Critical Diagnostic Testing by Supporting Saving Access to Laboratory Services Act - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO–(BUSINESS WIRE)–#digitalpathology–In a letter to the chairs and ranking members of the House Energy and Commerce Committee and Health Subcommittee, XiFin CEO L\u00e2le White urged policymakers to prioritize the Saving Access to Laboratory Services Act (SALSA) to set Medicare payments for clinical laboratory services on a stable and sustainable pathway. White\u2019s appeal supports the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-04T15:05:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231203612321\/en\/1957007\/21\/Xifin-Logo_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"XiFin CEO Urges Congress to Preserve Seniors\u2019 Access to Critical Diagnostic Testing by Supporting Saving Access to Laboratory Services Act\",\"datePublished\":\"2023-12-04T15:05:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/\"},\"wordCount\":598,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231203612321\\\/en\\\/1957007\\\/21\\\/Xifin-Logo_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/\",\"name\":\"XiFin CEO Urges Congress to Preserve Seniors\u2019 Access to Critical Diagnostic Testing by Supporting Saving Access to Laboratory Services Act - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231203612321\\\/en\\\/1957007\\\/21\\\/Xifin-Logo_RGB.jpg\",\"datePublished\":\"2023-12-04T15:05:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231203612321\\\/en\\\/1957007\\\/21\\\/Xifin-Logo_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231203612321\\\/en\\\/1957007\\\/21\\\/Xifin-Logo_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XiFin CEO Urges Congress to Preserve Seniors\u2019 Access to Critical Diagnostic Testing by Supporting Saving Access to Laboratory Services Act\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XiFin CEO Urges Congress to Preserve Seniors\u2019 Access to Critical Diagnostic Testing by Supporting Saving Access to Laboratory Services Act - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/","og_locale":"en_US","og_type":"article","og_title":"XiFin CEO Urges Congress to Preserve Seniors\u2019 Access to Critical Diagnostic Testing by Supporting Saving Access to Laboratory Services Act - Pharma Trend","og_description":"SAN DIEGO–(BUSINESS WIRE)–#digitalpathology–In a letter to the chairs and ranking members of the House Energy and Commerce Committee and Health Subcommittee, XiFin CEO L\u00e2le White urged policymakers to prioritize the Saving Access to Laboratory Services Act (SALSA) to set Medicare payments for clinical laboratory services on a stable and sustainable pathway. White\u2019s appeal supports the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/","og_site_name":"Pharma Trend","article_published_time":"2023-12-04T15:05:11+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231203612321\/en\/1957007\/21\/Xifin-Logo_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"XiFin CEO Urges Congress to Preserve Seniors\u2019 Access to Critical Diagnostic Testing by Supporting Saving Access to Laboratory Services Act","datePublished":"2023-12-04T15:05:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/"},"wordCount":598,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231203612321\/en\/1957007\/21\/Xifin-Logo_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/","url":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/","name":"XiFin CEO Urges Congress to Preserve Seniors\u2019 Access to Critical Diagnostic Testing by Supporting Saving Access to Laboratory Services Act - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231203612321\/en\/1957007\/21\/Xifin-Logo_RGB.jpg","datePublished":"2023-12-04T15:05:11+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231203612321\/en\/1957007\/21\/Xifin-Logo_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231203612321\/en\/1957007\/21\/Xifin-Logo_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/xifin-ceo-urges-congress-to-preserve-seniors-access-to-critical-diagnostic-testing-by-supporting-saving-access-to-laboratory-services-act\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"XiFin CEO Urges Congress to Preserve Seniors\u2019 Access to Critical Diagnostic Testing by Supporting Saving Access to Laboratory Services Act"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58519","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58519"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58519\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}